News Archive
-
Adamas Announces Positive Phase 3 Results for Treatment of Levodopa-induced Dyskinesia in Patients With PD
(December 23, 2015) – Adamas Pharmaceuticals, Inc. today announced that its Phase 3 EASE LID clinical trial evaluating the company’s investigational compound ADS-5102 (amantadine HCl) extended-release capsules for the treatment of levodopa-induce …
-
UCB Trials Wearable Sensor for Parkinson
(December 18, 2015) – UCB has begun trials of a wearable sensor that it is combining with a custom-made patient diary app to monitor the symptoms of Parkinson’s disease. Read more…
-
Pioneering Neuroprotective Results Achieved in Parkinson
(December 18, 2015) – A team of scientists at the University of Nebraska Medical Center (UNMC) and Longevity Biotech, Inc. demonstrated that neuroprotection could be attained in preclinical models by a novel drug candidate that changes immune responses …
-
LSVT LOUD® Symposium for People Living With Parkinson’s Disease Scheduled for 12.11.15 in New York City
(November 2, 2015) – LSVT Global is offering a two-hour interactive symposium on LSVT LOUD®, a physical and occupational therapy designed specifically for people living with Parkinson’s disease. The session will be held in Manhattan on …
-
Protecting the Brain from Parkinson
(December 8, 2015) – In 2013, a molecule called GM1 ganglioside showed promise in patients for not only relieving symptoms but also slowing disease progression. However, GM1 ganglioside has been difficult to make and to deliver to patients for regular …
-
Parkinson’s Institute and Clinical Center Publishes a Review on the State of Parkinson’s Research in Nature Genetics
(December 8, 2015) – The Parkinson’s Institute and Clinical Center is being recognized for its comprehensive analysis of the state of Parkinson’s research in a newly published article in Nature Genetics magazine. The Nature Genetics review …
-
Acorda Therapeutics Supports the National Disability Institute’s Financial Wellness Webinar Series
(November 30, 2015) – For the fifth year, Acorda Therapeutics will support the National Disability Institute’s Financial Wellness webinar series. NDI is a non-profit that exists to build better economic futures for individuals with disabili …
-
NeuroDerm Announces Streamlined U.S. Development Plan on ND0612H and ND0612L for the Treatment of PD
(November 11, 2015) – NeuroDerm announced that it has modified its U.S. development plan for ND0612H and ND0612L, the company’s continuous, subcutaneously delivered levodopa/carbidopa product candidates for the treatment of Parkinson’s disease. Based o …
-
Rock Steady Boxing: Fighting Back Against Parkinson’s in the Ring
(November 9, 2015) – On CBS Morning News, Lesley Stahl featured the work of Rock Steady Boxing and its therapeutic effects for those living with Parkinson’s disease, including her husband, Aaron Latham. Read more…
-
2015 Carnegie Center 5K and Fun Run for The Parkinson Alliance Raised Over $95,000 in Support of Parkinson’s Research
(Kingston, NJ, November 5, 2015) The Parkinson Alliance announced today that the 2015 Carnegie Center 5K and Fun Run, held last September 26th in Princeton, NJ, raised over $95,000 and net proceeds will go to Parkinson’s disease research. …
-
‘Outside the Box’ Reception Supports Parkinson
The ‘Outside the Box’ Reception was a private event held on October 25th in Altadena, CA. It was a spectacular evening of great music, great food, and supportive people coming together to raise funds to promote the innovative Parkinson’s disease …
-
Podcast Focusing on Cultivating Patience for Well Being in Parkinson
(November 2, 2015) – On Friday, November 13, 2015, at 12pm EST., Carol Walton, CEO of The Parkinson Alliance, and Neuropsychologist, Jeffrey Wertheimer, PhD, will join Mary Spremulli of Voice Aerobics for a podcast to discuss findings of Parkinso …
-
Gene Could Hold Key to Treating Parkinson
(October 27, 2015) – Researchers at King’s College London have identified a new gene linked to nerve function, which could provide a treatment target for “switching off” the gene in people with neurodegenerative diseases such as Parkinson’s …
-
Researchers Develop Techniques to Bypass Blood-Brain Barrier and Deliver Drugs to the Brain
(October 27, 2015) – Researchers at Massachusetts Eye and Ear/Harvard Medical School and Boston University have successfully shown neuroprotection in a Parkinson’s mouse model using new techniques to deliver drugs across the naturally impenetrabl …
-
Central Coast Follies Dancing for a Cure 2015
Mix together an exciting variety of music and dance styles depicting the Golden State from the 1800’s to 2013–including jazz, hip hop, and tap dance numbers to tunes by groups such as the Beach Boys, The Eagles, and Pentatonix, to name just a fe …